Vanderbilt Dialysis Clinic East
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Umeukeje, Ebele M
IRIS-CKD, NCT06906627: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1)

Not yet recruiting
N/A
800
US
(IRIS-CKD Screening Program): Home Kit, (IRIS-CKD Screening Program): Standard Lab Order
Duke University, Bayer, Boehringer Ingelheim, Eli Lilly and Company
Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM)
06/26
06/26
NCT05735743: MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Recruiting
N/A
150
US
Motivational interviewing, MI
Vanderbilt University Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
End Stage Renal Disease on Dialysis
11/27
11/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Umeukeje, Ebele M
IRIS-CKD, NCT06906627: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1)

Not yet recruiting
N/A
800
US
(IRIS-CKD Screening Program): Home Kit, (IRIS-CKD Screening Program): Standard Lab Order
Duke University, Bayer, Boehringer Ingelheim, Eli Lilly and Company
Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM)
06/26
06/26
NCT05735743: MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Recruiting
N/A
150
US
Motivational interviewing, MI
Vanderbilt University Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
End Stage Renal Disease on Dialysis
11/27
11/27

Download Options